1. IndiaInfoline
  2. Search
Displaying Results for "lupin"
Showing Results 1 - 19 of 1569

Lupin allots equity shares

capital market  | Mumbai October 17, 2014 12:29 IST

Under stock option plans

Lupin Limited - Allotment of Securities

capital market  | Mumbai October 17, 2014 00:00 IST

Lupin Limited has informed the Exchange that the Allotment Committee of Directors at its meeting held on October 17, 2014 has allotted 115369 fully paid up equity shares of Rs. 2/- each. These shares have been allotted upon exercising of options granted to the employees under Stock option plans of the Company.Further, the issued and paid up capital of the Company has been increased to Rs. 89,80,83,228 consisting 44,90,41,614 equity shares of Rs. 2/- each.

Lupin to hold board meeting

capital market  | Mumbai October 13, 2014 11:23 IST

On 28 October 2014

FII limit in Lupin may be hiked; stock up

India Infoline News Service  | Mumbai October 13, 2014 10:19 IST

The stock hit a high of Rs. 1,353 and a low of Rs. 1,317 on BSE

Lupin to hold board meeting

capital market  | Mumbai October 13, 2014 00:00 IST

Lupin will hold a meeting of the Board of Directors of the Company on 28 October 2014, to consider and take on record the unaudited financial results for the quarter ended 30 September 2014 (Q2).

Lupin Limited - ESOPs/ESOS/ESPS

capital market  | Mumbai October 10, 2014 00:00 IST

Lupin Limited has informed the Exchange that on October 8, 2014, the Company has granted 4500 options to their employees under Lupin Employees Stock Option Plan 2011, at the exercise price of Rs. 1368.05. Company has informed that that one equity share of 2/- each is covered by each option. The options issued are exercisable at the market price as defined in SEBI guidelines, in a phased manner after a minimum vesting period of 12 months but before the exercise period of 10 years from the date of grant.

Lupin Limited - Acquisition

capital market  | Mumbai October 07, 2014 00:00 IST

Lupin Limited has informed the Exchange that in continuation of the Company's letter dated March 27, 2014, informing about the acquisition of 100% equity stake in Laboratories Grin, S.A. DE C.V., Mexico, ('Lab Grin'), subject to certain closing conditions.The Company has now informed that the closing conditions of the said acquisition were completed on September 30, 2014. Consequent to which, Lab Grin has become a wholly-owned subsidiary of the Company w.e.f. September 30, 2014.

Lupin allots equity shares

capital market  | Mumbai September 25, 2014 13:36 IST

Under stock option plans

Lupin allots equity shares

capital market  | Mumbai September 25, 2014 00:00 IST

Lupin announced that the Allotment Committee of Directors at its meeting held on 25 September 2014, has allotted 120447 fully paid up equity shares of Rs. 2/- each. These shares have been allotted upon exercising of options granted to the employees under Stock option plans of the Company.<p>In view of the above, the issued and paid up capital of the Company has been increased to Rs. 89,78,52,490 consisting 44,89,26,245 equity shares of Rs. 2/- each.

Lupin Limited - ESOPs/ESOS/ESPS

capital market  | Mumbai September 25, 2014 00:00 IST

Lupin Limited has informed the Exchange that the Allotment Committee of Directors at its meeting held on September 25, 2014 has allotted 120447 fully paid up equity shares of Rs. 2/- each. These shares have been allotted upon exercising of options granted to the employees under Stock option plans of the Company.In view of the above, the issued and paid up capital of the Company has been increased to Rs. 89,78,52,490 consisting 44,89,26,245 equity shares of Rs. 2/- each.

Lupin closes down ~3.69%; ties up with Merck Serono

India Infoline News Service  | Mumbai September 16, 2014 16:41 IST

Lupin had hit a high of Rs. 1,442 and a low of Rs. 1,351 on BSE

Lupin enters into long term strategic partnership with Merch Serono

capital market  | Mumbai September 16, 2014 16:01 IST

For expansion in emerging markets

Lupin ties up with Merck Serono; stock down ~3%

India Infoline News Service  | Mumbai September 16, 2014 14:53 IST

Lupin will support Merck Serono in the implementation of the company's General Medicines portfolio expansion initiative in emerging markets

Lupin enters into long term strategic partnership with Merch Serono

capital market  | Mumbai September 16, 2014 00:00 IST

Lupin announced today that it has entered into a long term strategic partnership with Merck Serono, the Biopharmaceutical division of Merck. <p>Lupin will support Merck Serono in the implementation of the company's General Medicines portfolio expansion initiative in emerging markets thus addressing local needs for affordable, high quality medicines. <p>The agreement builds on an established working relationship between the two companies, and could add up to 20 new products to the current portfolio. The first launches are expected in 2016.

Lupin Limited - Press Release

capital market  | Mumbai September 16, 2014 00:00 IST

Lupin Limited has informed the Exchange regarding a press release dated September 16, 2014 titled Lupin Announces Strategic Alliance for Emerging Markets.

Lupin gains after inking pact to sell US-based Salix's drugs in Canada

capital market  | Mumbai September 15, 2014 16:07 IST

Lupin rose 4.03% to Rs 1,414 on BSE after the company said it entered into an agreement with US-based Salix Pharmaceuticals to market the latter's two products in Canada.

Lupin hits day's high

India Infoline News Service  | Mumbai September 15, 2014 15:05 IST

Lupin opened at Rs. 1,359 and hit a high of Rs. 1395 on BSE

Lupin up ~2%; Co may sign deal with Merck Serono

India Infoline News Service  | Mumbai September 15, 2014 13:42 IST

Lupin opened at Rs. 1,359 and hit a high of Rs. 1386 on BSE

Lupin Limited - Press Release

capital market  | Mumbai September 15, 2014 00:00 IST

Lupin Limited has informed the Exchange regarding press release dated September 12, 2014 titled Lupin and Salix Announce Exclusive Distribution Agreement for Canada Zaxine , Relistor and Other Gastroenterology Products.

Back to Top

 

 
 
 
Recent Reports
News